The Mycoplasma Testing Market is expanding as laboratories adopt advanced techniques to ensure biologics and vaccines are contamination-free. Mycoplasma Testing Market analysis emphasizes the role of automated platforms, PCR-based detection, and rapid assays in improving testing reliability and turnaround times. Investments in laboratory automation, staff training, and compliance measures...

The US Mycoplasma Testing Market trajectory continues to point toward sustained expansion as the biopharmaceutical industry embraces advanced manufacturing and personalized medicine. With therapeutic modalities becoming increasingly cell-based and complex, the margin for contamination error continues to narrow. The ongoing development of closed, automated manufacturing systems is creating...